GABA (((A) 受容体アルファ4サブユニットの抑制は,内生性ステロイドの離脱特性を防止します
1Department of Neurobiology and Anatomy, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania 19129, USA. smiths@auhs.edu
Nature
|May 15, 1998
まとめ
ネズミのプロゲステロン離脱は,GABA強化剤である3alpha,5alpha-THPの脳レベルを低下させることで,月経前症候群 (PMS) の症状を模倣します. これにより,発作の感受性が高まり,GABA (((A)) 受容体の発現が変化します.
科学分野:
- 神経科学は神経科学である.
- エンドクリノロジー エンドクリノロジー
- 薬理学 薬理学とは
背景:
- プロゲステロンは脳内で3alpha,5alpha-THPに変換され,GABAergic機能を強化します.
- 低レベルの3α,5α-THPは,不安や発作などの前月経症候群 (PMS) の症状と相関しています.
- 鎮静剤の離脱は,PMSのような症状を引き起こす可能性があります.
研究 の 目的:
- プロゲステロン離脱に起因する変化の根底にある神経生物学的メカニズムを調査する.
- PMSと産後症候群のラットモデルを確立する.
主な方法:
- ラットにおけるプロゲステロン離脱のパラダイムを開発した.
- 発作の感受性およびベンゾジアゼピンに対する感受性の測定.
- GABA (A) 受容体のサブユニットの遺伝子転写を分析した.
- 評価されたGABA現在の崩壊時間.
主要な成果:
- プロゲステロン中断は,発作の感受性およびベンゾジアゼピン無感性を増加させた.
- 3α,5α-THP濃度の低下は,GABA (((A)) 受容体のα4サブユニット遺伝子転写の低下と関連していた.
- 発作の感受性は,GABA電流の衰退時間を短縮したことに起因した.
- アルファ4遺伝子トランスクリプトをブロックすることで,離脱症状を防ぐことができました.
結論:
- プロゲステロン離脱はGABA (A) 受容体のサブユニット発現を変化させ,PMSの症状に寄与する.
- GABAergic阻害の変化は,プロゲステロン離脱効果において重要な役割を果たします.
- ネズミのモデルは,PMSに関連する神経学的変化を効果的に真似しています.
関連する概念動画
GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...


